SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Organovo (ONVO)
ONVO 2.360-12.6%Nov 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: yofal who wrote (45)2/24/2013 5:02:05 PM
From: Doren  Read Replies (1) of 171
 
Yes long article. Was wondering if you could copy and paste page two for those of us who aren't registered.

I've always been shy investing in the biochem business due to the vagaries and cost involved in FDA trials etc.

Things that intrigue me about ONVO:

I doubt they will have to go through any FDA trials if all they are doing is supplying tissue FOR the trials. That's huge. Eventually they may have to go through trials but if I understand correctly that's a long way off. I can see them successful before they reach those hurdles.

Stem cell research would seems to reward ONVO as time goes on.

Cell clones can be taken from patients and grown to supply medium for printing, obviating much of the tissue rejection that has been a problem with transplants.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext